• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CAPIOX RX25 OXYGENATOR EAST; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CAPIOX RX25 OXYGENATOR EAST; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*RX25RE
Medical Device Problem Codes Break (1069); Leak/Splash (1354)
Health Effect - Clinical Code No Patient Involvement (2645)
Date of Event 08/28/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Terumo has received the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
 
Event or Problem Description
The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during priming, there was a leak on the oxygenator and upon inspection, it was found to be broken.No patient involvement as this occurred during prime.Product was changed out.Procedure was completed successfully.
 
Additional Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on october 8, 2018.(b)(4).The returned sample was confirmed to have damage to the blood inlet port.A retention sample from the same product code and lot number combination was inspected and there was no damage anywhere on the device, specifically none to the blood inlet port on the oxygenator.All oxygenators are 100% visually inspected at several points in the production process.The packaging of the product also ensures protection against damage to any ports of the oxygenator.It is likely that the blood inlet port was damaged by a shock force at some point during the handling of the product; however, when or how this shock force was applied was not able to be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX RX25 OXYGENATOR EAST
Common Device Name
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
MDR Report Key7944406
Report Number1124841-2018-00249
Device Sequence Number13788971
Product Code DTZ
UDI-Device Identifier00699753450103
UDI-Public(01)00699753450103
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
K153213
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source distributor,health profession
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/30/2021
Device Model Number3CX*RX25RE
Device Catalogue NumberN/A
Device Lot NumberWF14
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/26/2018
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 09/18/2018
Supplement Date Received by Manufacturer10/17/2018
Initial Report FDA Received Date10/08/2018
Supplement Report FDA Received Date10/19/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-